| HR (95% CI) | p |
---|---|---|
Age (per year) | 1.11 (1.04–1.18) | 0.001 |
Sex (male) | 0.65 (0.28–1.51) | 0.320 |
ACS at presentation (presence) | 0.99 (0.41–2.41) | 0.983 |
CV risk profile | ||
 BMI (per kg/m2) | 0.91 (0.82–1.00) | 0.059 |
 Waist circumference (per 10 cm) | 0.94 (0.68–1.30) | 0.718 |
 Hypertension (presence) | 0.94 (0.28–3.17) | 0.923 |
 Hyperlipidemia (presence) | 0.70 (0.30–1.66) | 0.704 |
 Total cholesterol (per 10 mg/dl) | 1.05 (0.95–1.16) | 0.313 |
 LDL-c (per 10 mg/dl) | 1.07 (0.94–1.21) | 0.311 |
 HDL-c (per 10 mg/dl) | 1.43 (1.02–1.99) | 0.036 |
 Triglycerides (per 10 mg/dl) | 0.98 (0.92–1.04) | 0.447 |
 Active smoking (presence) | 0.99 (0.37–2.66) | 0.981 |
 Pack years (per 10 py) | 0.95 (0.79–1.16) | 0.637 |
 Family history of CAD (presence) | 0.35 (0.14–0.89) | 0.351 |
 Previous CAD (presence) | 1.99 (0.88–4.52) | 0.099 |
 Previous PCI (presence) | 1.93 (0.85–4.41) | 0.118 |
 Previous CABG (presence) | 2.29 (0.31–17.1) | 0.418 |
 hsCRP (per 10 mg/dl) | 1.06 (0.93–1.22) | 0.375 |
 GFR (per 10 mg/dl/1.73 m2) | 0.49 (0.27–0.90) | 0.020 |
Other comorbidities | ||
 COPD (presence) | 1.30 (0.44–3.48) | 0.638 |
Diabetes severity and therapy | ||
 Diabetes duration (per year) | 1.03 (0.99–1.06) | 0.125 |
 Diabetic polyneuropathy (presence) | 2.94 (1.29–6.68) | 0.010 |
 Diabetic retinopathy (presence) | 1.90 (0.75–4.82) | 0.178 |
 HbA1c (per 1%) | 1.34 (0.92–1.97) | 0.131 |
 Insulin (presence) | 3.44 (1.45–8.13) | 0.005 |
 Metformin (presence) | 0.40 (0.17–0.90) | 0.028 |
 Sulfonylamides (presence) | 0.73 (0.25–2.16) | 0.575 |
 Incretins (presence) | 2.11 (0.87–5.14) | 0.100 |
Other relevant medication | ||
 Aspirin (presence) | 1.21 (0.16–8.96) | 0.854 |
 Statin (presence) | 0.54 (0.24–1.24) | 0.149 |
 ACE or ARBi (presence) | 0.76 (0.31–1.85) | 0.547 |
 Beta-blocker (presence) | 0.52 (0.22–1.24) | 0.142 |